Tag Archives: Kidney Volume

Measurement of murine kidney functional biomarkers using DCE-MRI: A multi-slice TRICKS technique and semi-automated image processing algorithm

Kai Jiang et al. Measurement of murine kidney functional biomarkers using DCE-MRI: A multi-slice TRICKS technique and semi-automated image processing algorithm. Magnetic Resonance Imaging. Publication Date August 20, 2019 How Analyze was Used “Image analysis. Reference kidney volume was measured from the 3D-FISP images using Analyze version 12.0. Renal volume was measured by manual segmentation.”…

Urinary Biomarkers Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease Progression

A. Lianne Messchendorp et al. Urinary Biomarkers Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease Progression. KI Reports. October 13, 2017. Publication Date October 2017 How Analyze was Used “TKV was measured on T2-weighted coronal images using Analyze software (AnalyzeDirect, Inc., Overland Park, KS) by classical volumetry (ie, manual tracing)…

High Resolution Ultrasonography for Assessment of Renal Cysts in the PCK Rat Model of Autosomal Recessive Polycystic Kidney Disease

S. Kapoor1,2, D. Rodriguez1,3, K. Mitchell4, R.P. W├╝thrich1,2. High Resolution Ultrasonography for Assessment of Renal Cysts in the PCK Rat Model of Autosomal Recessive Polycystic Kidney Disease. Kidney & Blood Pressure Research. March 17th, 2016. Full Text – Open Access Publication Date March 2016 How Analyze was Used “The 2-D transverse cineloops were exported from…

Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease

Cadnapaphornchai MA, George DM, McFann K, Wang W, Gitomer B, Strain JD, Schrier RW. Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. May 2014;9(5):889-896. Publication Date May 2014 How Analyze was Used “Digital Imaging and Communications in Medicine…

Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to halt disease progression in autosomal dominant polycystic kidney disease

Meijer E, Drenth JP, d’Agnolo H, Casteleijn NF, de Fijter JW, Gevers TJ, Kappert P, Peters DJ, Salih M, Soonawala D, Spithoven EM, Torres VE, Visser FW, Wetzels JF, Zietse R, Gansevoort RT. Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to halt disease progression…